AffiAB®​ Anti-SARS-CoV-2 Spike RBD Antibody, Chimeric mAb, Human IgA1 (AM130) (MALS verified)

Specifications

Technique
Antibody

Description

Anti-SARS-CoV-2 Spike RBD Antibody, Chimeric mAb, Human IgA1 (AM130) is a chimeric monoclonal antibody combining the constant domains of the human IgA1 molecule with mouse variable regions.

Additional Attributes

Host
Human
Isotype
IgA1
Technique
Antibody
Technique
Monoclonal
Brand
AffiAB